Yves A. De Clerck

Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.

Toshiyuki Yoneda, Akira Sasaki, Colin R. Dunstan et al. · Journal of Clinical Investigation · 1997 · 248 citations · Full text

Breast Oncology, Pathology, Matrix Metalloproteinase-2 +21

cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases.

Thomas C. Boone, Martin Johnson, Yves A. De Clerck et al. · Proceedings of the National Academy of Sciences · 1990 · 200 citations

Purification and Characterization of Two Related but Distinct Metalloproteinase Inhibitors Secreted by Bovine Aortic Endothelial Cells

Yves A. De Clerck, T D Yean, Barry Ratzkin et al. · Journal of Biological Chemistry · 1989 · 194 citations · Full text

Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2)

Yves A. De Clerck, Martine I. Darville, Yves Eeckhout et al. · Gene · 1994 · 111 citations

Transcriptional Regulation, Signal Transduction, Protein Expression +7

Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways.

A M Montgomery, Yves A. De Clerck, K E Langley et al. · PubMed · 1993 · 106 citations

Melanoma-mediated Dissolution, Pathology, Dermatology +18